MY138266A - Treatment of neuropathy - Google Patents

Treatment of neuropathy

Info

Publication number
MY138266A
MY138266A MYPI20024290A MY138266A MY 138266 A MY138266 A MY 138266A MY PI20024290 A MYPI20024290 A MY PI20024290A MY 138266 A MY138266 A MY 138266A
Authority
MY
Malaysia
Prior art keywords
neuropathy
treatment
pregabalin
gabapentin
gmp
Prior art date
Application number
Inventor
Eliot Richard Dr Forster
Nandan Parmanand Koppiker
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MY138266A publication Critical patent/MY138266A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

THE PRESENT INVENTION DESCRIBES A COMBINATION COMPRISING A C-GMP PDE5 INHIBITOR WITH GABAPENTIN OR PREGABALIN, PARTICULARLY FOR THE TREATMENT OF NEUROPATHY.
MYPI20024290 1999-10-21 2000-10-19 Treatment of neuropathy MY138266A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9924958.3A GB9924958D0 (en) 1999-10-21 1999-10-21 Treatment of neuropathy

Publications (1)

Publication Number Publication Date
MY138266A true MY138266A (en) 2009-05-29

Family

ID=10863154

Family Applications (2)

Application Number Title Priority Date Filing Date
MYPI20004933 MY127989A (en) 1999-10-21 2000-10-19 Treatment of neuropathy
MYPI20024290 MY138266A (en) 1999-10-21 2000-10-19 Treatment of neuropathy

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MYPI20004933 MY127989A (en) 1999-10-21 2000-10-19 Treatment of neuropathy

Country Status (3)

Country Link
GB (1) GB9924958D0 (en)
MY (2) MY127989A (en)
NZ (1) NZ507690A (en)

Also Published As

Publication number Publication date
GB9924958D0 (en) 1999-12-22
MY127989A (en) 2007-01-31
NZ507690A (en) 2002-10-25

Similar Documents

Publication Publication Date Title
HU0004120D0 (en)
GB2382110A (en) Clutch assembly
WO2002074293A3 (en) Methods for restoring cognitive function following systemic stress
MXPA02012494A (en) A thiazine oxazolidinone.
MY135233A (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
MXPA04002382A (en) Herbicide and safening combinations.
HK1051639A1 (en) Buckle.
YU89503A (en) Use of osteopontin for the treatment and/or prevention of neurologic diseases
PL324330A1 (en) Do- and trivalent low-molecule selectin inhibitors
IL142900A0 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
MXPA03002861A (en) Retinoids for the treatment of emphysema.
EP1262556A3 (en) Antimicrobial peptides and method for identifying and using such peptides
WO2002095402A3 (en) Individualization of therapy with hyperlipidemia agents
NZ320259A (en) Deodorizing preparations containing cationic biopolymers, aluminium hydrochlorate and esterase inhibitors
MY138266A (en) Treatment of neuropathy
CA98129S (en) Storage case
WO2002088714A3 (en) Individualization of therapy with antineoplastic agents
EP1406605A4 (en) Carbamates of 2-heterocyclic-1,2-ethanediols
WO2002093162A3 (en) Individualization of therapy with antibiotic agents
AU7919698A (en) Formic acid solution with reduced corrosive effect
EP1351680B8 (en) Use of anethole-dithiolethione for preventing and treating drug-induced tendon toxicity
HK1044028A1 (en) New specrophotometric assay for detecting hemoglobin degradation.
HK1064940A1 (en) Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity
HK1050120A1 (en) Watchband.
AU1393102A (en) Use of carnitine for enhancing training-induced bradycardia